Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
The progressive neurological condition affects more than six million people worldwide
Read Moreby Jen Brogan | May 1, 2024 | News | 0
The progressive neurological condition affects more than six million people worldwide
Read Moreby Jen Brogan | Sep 15, 2023 | News | 0
The method could also be beneficial for Parkinson’s disease and strokes
Read Moreby Lucy Parsons | Apr 12, 2021 | News | 0
Device designed to help clinicians detect lesions in the colon during a colonoscopy
Read Moreby Lucy Parsons | Oct 29, 2020 | News | 0
Agreement will also see companies develop treatments for frontotemporal dementia
Read Moreby Selina McKee | Aug 30, 2018 | News | 0
UK analytics group Genomics plc has signed a three-year deal with Vertex centred on improving the discovery of targets for precision medicine, and has also raised £25 million to further expand its business.
Read Moreby Selina McKee | Mar 15, 2018 | News | 0
BenevolentAI has teamed up with Action Against AMD* to find treatments and a potential cure for age-related macular degeneration, the leading cause of blindness in the UK.
Read Moreby Selina McKee | Dec 5, 2017 | News | 0
Merck Sharp & Dohme and Telefonica’s Wayra UK have unveiled the next focus of their digital health innovation accelerator programme, calling on tech start-ups to “re-imagine healthcare” with the help of artificial intelligence and machine learning.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
